TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 3 | -3 | -2 | -11 | 23 | -20 | -2 |
| P | %wins | 100 | 0 | 0 | 0 | 100 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/15/14 16:05 | 7/11/14 | OCRX | Ocera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tetlow Sharon | CA | O | Acting C | P | 17 | 5.83 | 1 | 3 | New | 3 | D | -88 | -4 | -61 | -33 | -15 | -20 | -22 | -17 | 3 | -3 | -2 | -11 | 23 | -20 |
6/8/05 20:11 | 6/8/05 | CEGE | Cell Genesys Inc | DE | Health | Drug | Pharmaceutical Preparations | Tetlow Sharon | CA | O | SVP,CFO | P | 12 | 4.91 | 0 | 3 | New | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |